bioRxivNeurosciencePreprint
Striatal compartmentalization and clustering of different subtypes of astrocytes is altered in the zQ175 Huntington's disease mouse model
Taylor G. BrowniD, Mackenzie N. Thayer, Nicole ZarateiD, Rocío Gómez‐PastoriD
Abstract
Huntingtons disease (HD) is a devastating neurodegenerative disease that primarily affects the striatum, a brain region that controls movement and some forms of cognition. Dysfunction and loss of medium spiny neurons of the striatum is accompanied by astrogliosis (increased astrocyte density and pathology). For decades, astrocytes were considered a homogeneous cell type, but recent transcriptomic analyses revealed astrocytes are a heterogeneous population classified into multiple subtypes depending on the expression of different gene markers. Here, we studied whether three different striatal astrocyte subtypes expressing glutamine synthetase (GS), glial fibrillary acidic protein (GFAP), or S100 calcium-binding protein B (S100B) are differentially altered in HD. We conducted a comparative immunofluorescence analysis in the striatum of WT and the heterozygous zQ175 HD mouse model and found that the expression and abundance of GFAP+ and S100B+ astrocytes increased in zQ175 mice, while GS+ astrocytes showed no alteration. We then explored whether there was a differential spatial distribution of any of these subtypes within the striatum. We developed a systematic brain compartmentalization approach and found that while GS+ and S100B+ astrocytes were more homogeneously distributed throughout the striatum in zQ175 mice, GFAP+ astrocytes preferentially accumulated in the dorsomedial and dorsolateral striatum, which are regions associated with goal-directed and habitual behaviors. Additionally, GFAP+ astrocytes in zQ175 mice showed increased clustering, a parameter that indicates increased proximity and that is associated with localized inflammation and/or neurodegeneration. Our data suggest a differential susceptibility in both increased density and striatal compartmentalization of different subtypes of astrocytes in zQ175. These results highlight new potential implications for our understanding of astrocyte pathology in HD.
- organism: mouse
- assay: protein structure
- research focus: cell type annotation
- approach: experimental assay
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Enhanced Hippocampal Spare Capacity in Q175DN Mice Despite Elevated mHTT Aggregation
Melissa A Solem, Ross J. Pelzel, … Rocío Gómez‐Pastor·bioRxiv·Oct 14, 2024
- Astrocytic engagement of the corticostriatal synaptic cleft is disrupted in a mouse model of Huntington disease
Carlos Benitez Villanueva, Hans Jacob Teglbjærg Stephensen, … Steven A. Goldman·bioRxiv·Dec 6, 2022
- Molecular unbalances between striosome and matrix compartments characterize the pathogenesis of Huntington's disease model mouse
Ryoma Morigaki, Tomoko Yoshida, … Ann M. Graybiel·bioRxiv·Jul 20, 2025
- Integrated transcriptome analysis of Huntingtons disease iPSC-derived and mouse astrocytes implicates dysregulated synaptogenesis, actin, and astrocyte maturation
Andrea M. Reyes-Ortiz, Edsel M. Abud, … Leslie Michels Thompson·bioRxiv·Jul 28, 2022
- Human Neural Stem Cells Differentiate and Integrate, Innervating Implanted zQ175 Huntington's Disease Mouse Striatum
Sandra M. Holley, Jack C. Reidling, … Leslie Michels Thompson·bioRxiv·Jan 18, 2021
- In vivo MR spectroscopy reflects synapse density in a Huntington's disease mouse model
Nicole Zarate, Katherine Gundry, … Rocío Gómez‐Pastor·bioRxiv·Oct 26, 2021